Curoverse, Inc. — Form D/A
Curoverse, Inc. of BOSTON, MA, a company, filed a Form D amendment with the SEC on 2014-02-19. The offering totals $1.7M, of which $1.7M was reported sold. Industry: Other.
Offering
- Filed: 2014-02-19
- Form: D/A
- Accession: 0001586571-14-000003
- Industry: Other
- Exemptions: 06b
- Total offering: $1.7M
- Amount sold: $1.7M
- Investors: 15
- Date of first sale: 2013-08-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-202740
Issuer
- Name: Curoverse, Inc.
- CIK: 0001586571
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 332 CONGRESS STREET, BOSTON, MA, 02210
- Phone: 617-937-2300
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Michael Dial | Director | Durham, NC |
| David Martirano | Director | Boston, MA |
| Jeremy Allaire | Director | New York, NY |
| Alexander Wait Zaranek | Director | Boston, MA |
| Adam Berrey | Director | Boston, MA |
| Adam Berrey | Executive Officer | Boston, MA |
| Clay Throp | Director | Boston, MA |
| Ward Vandewege | Executive Officer | Boston, MA |
Other filings by this issuer (2)
More